Compounds > cyproterone acetate, ethinyl estradiol drug combination
Page last updated: 2024-08-26

cyproterone acetate, ethinyl estradiol drug combination and Deep Vein Thrombosis

cyproterone acetate, ethinyl estradiol drug combination has been researched along with Deep Vein Thrombosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wooltorton, E1
Ford, AR; Lexchin, J; Lippman, A; Mintzes, B1
Rowe, TC1

Other Studies

3 other study(ies) available for cyproterone acetate, ethinyl estradiol drug combination and Deep Vein Thrombosis

ArticleYear
Diane-35 (cyproterone acetate): safety concerns.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003, Feb-18, Volume: 168, Issue:4

    Topics: Androgen Antagonists; Canada; Consumer Product Safety; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Factors; United Kingdom; Venous Thrombosis; Women's Health

2003
Too much disclosure of product risks? CBC television, SOGC, and Diane-35.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2003, Volume: 25, Issue:4

    Topics: Acne Vulgaris; Advertising; Androgen Antagonists; Canada; Cyproterone Acetate; Disclosure; Drug Combinations; Ethinyl Estradiol; Female; Humans; Odds Ratio; Risk Factors; United States; Venous Thrombosis

2003
First-use risks.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003, May-27, Volume: 168, Issue:11

    Topics: Androgen Antagonists; Canada; Consumer Product Safety; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Assessment; Risk Factors; Thromboembolism; Venous Thrombosis

2003